New Key Statistics Module, Z-Score and F-Score
NYSE:TAK Key Ratios
Market Cap $ M | 41,513.49 |
Enterprise Value $ M | 69,588.43 |
P/E(ttm) | 32.91 |
PE Ratio without NRI | 32.91 |
Forward PE Ratio | 23.30 |
Price/Book | 0.95 |
Price/Sales | 1.56 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 17.06 |
Payout Ratio % | 1.57 |
Revenue (TTM) $ M | 29,415.00 |
EPS (TTM) $ | 0.40 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | 6.10 |
5-y EBITDA Growth Rate % | 10.00 |
y-y EBITDA Growth Rate % | -2.00 |
EV-to-EBIT | 30.38 |
EV-to-EBITDA | 9.12 |
PEG | 3.29 |
Shares Outstanding M | 3,137.83 |
Net Margin (%) | 4.28 |
Operating Margin % | 8.08 |
Pre-tax Margin (%) | 3.56 |
Quick Ratio | 0.55 |
Current Ratio | 1.06 |
ROA % (ttm) | 1.25 |
ROE % (ttm) | 2.68 |
ROIC % (ttm) | 3.00 |
Dividend Yield % | 4.76 |
Altman Z-Score | 1.04 |
TAK Number of Guru Trades
TAK Volume of Guru Trades
Gurus Latest Trades with NYSE:TAK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TAK is held by these investors
Total 1
Takeda Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about NYSE:TAK
Total 0- 1